Banca Mediolanum Spa BANCA MEDIOL.../ IT0004776628 /
| 5/24/2024 5:29:50 PM | Chg. - | Volume | Bid9:10:26 AM | Ask9:10:26 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.58EUR | - | 328,856 Turnover: 3.29 mill. |
10.24Bid Size: 5,000 | 10.76Ask Size: 5,000 | 7.86 bill.EUR | - | 9.51 |
GlobeNewswire
6/3
Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascula...
GlobeNewswire
2/7
The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, fir...
GlobeNewswire
11/7/2023
Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in stroke
GlobeNewswire
9/14/2023
Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatm...
GlobeNewswire
4/15/2021
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inoli...
GlobeNewswire
1/19/2021
Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance...
